Mood Disorders Linked to the Reproductive Cycle in Women
Barbara L. Parry* and Patricia Haynes
Department of Psychiatry
University of California, San Diego
La Jolla, California 92093
tel: (619) 543-5592
fax: (619) 543-5462
REFERENCES
1.
Albers EH, Gerall AA, Axelson JF. Effect of reproductive
state on circadian periodicity in the rat. Physiol Behav 1981;26:21-25.
2.
Altshuler LL, Hendrick V, Parry B. Pharmacological
management of premenstrual disorder. Harvard Rev Psychiatry 1995;2:233-245.
3.
Appleby L, Warner R, Whitton A, Faragher B. A controlled
study of fluoxetine and cognitive-behavioural counselling in the treatment of
postnatal depression. Br Med J (Clinical Research Ed.) 1997;314:932-936.
4.
Amino N, More H, Iwatani Y, et al. High prevalence
of transient postpartum thyrotoxicosis and hypothyroidism. N Engl J Med 1982;306:849-852.
5.
Austin MV, Mitchell PB. Use of psychotropic medications
in breast-feeding women: acute and prophylactic treatment. Australian and New
Zealand Journal of Psychiatry 1998;32:778-784.
6.
Axelson JF, Gerall AA, Albers E. Effect of progesterone
on the estrous activity cycle of the rat. Physiol Behav 1981;26:631-635.
7.
Baker ER, Best RG, Manfredi, RL, Demers LM, Wolf
GC. Efficacy of progesterone vaginal suppositories in alleviation of nervous
symptoms in patients with premenstrual syndrome. J of Assisted Reprod Gen 1995;12:205-209.
8.
Bancroft J, Boyle H, Warner P, Fraser HM. The use of an LHRH agonist, buserelin, in the
long term management of premenstrual syndromes. Clin Endocrinol 1987;27:171-182.
9.
Berman KF, Schmidt PJ, Rubinow DR, Danaceau MA,
Van Horn JD, Esposito G, Ostrem JL, Weinberger DR. Modulation of cognition-specific
cortical activity by gonadal steroids: A positron-emission tomography study
in women. Neurobiology 1997;94:8836-41.
10.
Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart
KL. Efficacy of depot leuprolide in premenstrual syndrome: Effect of symptom
severity and type in a controlled trial. Obstet Gyn 1994;84:779-786.
11.
Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma
of women with premenstrual syndrome. Am
J Obstet Gynecol 1984;150:363-366.
12.
Budoff PW. The
use of prostaglandin inhibitors for the premenstrual syndrome. J Repro Med 1983;28:469-478.
13.
Callender K, McGregor M, Kirk P, Thomas CS. A double-blind trial of evening primrose oil
in the premenstrual syndrome: Nervous symptom subgroup. Human Psychopharm 1988;3:57-61.
14.
Chang KD, Keck PE Jr., Stanton SP, McElroy SL,
Strakowski SM, Geracioti TD Jr. Differences in thyroid function between bipolar
manic and mixed states. Biol Psychiatry 1998;43:730-733.
15.
Cho JT, Bone S, Dunner DL, et al. The effects of
lithium treatment on thyroid function in patients with primary affective disorder.
Am J Psychiatry
1979;136:115-116.
16.
Chuong CJ, Coulam CB, Bergstralh EJ, O'Fallon WM,
Steinmetz GI. Clinical trial of naltrexone
in premenstrual syndrome. Obstet Gynecol
1988;72:332-336.
17.
Cohen L, Heller VL. On the use of anticonvulsants
for manic depression during pregnancy. Psychosomatics 1990;31:462-464.
18.
Coryell W, Endicott J, Kuler M. Rapid cycling affective disorder: Demographics,
diagnosis, family history and course. Arch Gen Psychiatry 1992;49:126-131.
19.
Cowdry RW, Wehr TA, Zis AP, Goodwin FK. Thyroid
abnormalities associated with rapid cycling bipolar illness. Arch Gen Psychiatry 1983;40:414-420.
20.
Dalton K. Progesterone, fluid and electrolytes
in the premenstrual syndrome. Br Med
J 1980;281:1008-1009.
21.
Dalton K. Progesterone
prophylaxis used successfully in postnatal depression. Practioner 1985;229:507-508.
22.
Dalton K. The Premenstrual Syndrome. London: Heineman Medical;1964
23.
Dennerstein L, Spencer-Gardener C, Gotts G. Progesterone and the premenstrual syndrome:
A double-blind cross-over trial. Br
Med J 1985;290:1617-1621.
24.
Edwards JG, Anderson I. Systematic review and guide
to selection of selective serotonin reuptake inhibitors. Drugs 1999; 57:507-33.
25.
Elsner CW, Buster JE, Schindler RA, Nessin SA,
Abraham GE. Bromocriptine treatment
of premenstrual tension syndrome. Obstet
Gynecol 1980;56:723-726.
26.
Eriksson E, Hedberg MA, Andersch B, Sundblad C.
The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline
reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmocology
1995;12:167-176.
27.
Facchinetti F, Borella P, Sances G, Fioroni L,
Nappi RE, Genazzani AR. Oral magnesium
successfully relieves premenstrual mood changes. Obstet Gynecol 1991;78:177-181.
28.
Freeman E, Rickels K, Sondheimer SJ, Polansky M.
Ineffectiveness of progesterone suppository treatment for premenstrual
syndrome (see comments). JAMA 1990;264:349-353.
29.
Freeman EW, Rickels K, Arredondo F, Kao L, Pollack
SE, Sondheimer SJ. Full- or half-cycle treatment of severe premenstrual syndrom
with a serotonergic antidepressant. J of Clin Psychopharmacology 1999;19:3-8.
30.
Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing
hormone agonist in the treatment of premenstrual symptoms with and without ongoing
dysphoria: A controlled study. Psychopharm Bull 1997;33:303-309.
31.
Garvey MJ, Tuason VB, Lumry AE, et al. Occurrence
of depression in the postpartum state. J Affect Disord 1983;5:97-101.
32.
Giannini AJ, Sullivan B, Sarachene J, Loiselle
RH. Clonidine in the treatment of premenstrual
syndrome: A subgroup study. J Clin Psychiatry
1988;49:62-63.
33.
Glick ID, Stewart D. A new drug treatment for premenstrual exacerbation of schizophrenia.
Compr Psychiatry 1980;21:281-287.
34.
Goodwin FK, Jamison KR. The natural course of manic
depressive illness. In Post RM, Ballenger
JC (eds): Neurobiology of Mood Disorders. Baltimore/London:
Williams and Wilkins;1984
35.
Gunston KD. Premenstrual
syndrome in Cape Town. Part II.
A double-blind placebo-controlled study of the efficacy of mefenamic
acid. S Afr Med J 1986;70:159-160.
36.
Hagnell 0, Lanke J, Roisman B, et al. Are we entering
an age of melancholy? Depressive illness and prospective epidemiological study
over 25 years. The Lundby Study, Sweden.
Psychol Med 1982;12:279-289.
37.
Hahn PM, Van Vugt DA, Reid RL. A randomized, placebo-controlled,
crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology
1995; 20:193-209.
38.
Halbreich U. Role of estrogen in postmenopausal
depression. Neurology 1997;48 (Suppl 7):S16-S20.
39.
Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual
changes and changes in gonadal hormones. Acta Psychother Scand 1986;74:576.
40.
Halbreich U, Smoller JW. Intermittent luteal phase
sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997;58:399-402.
41.
Halbreich U, Tworek H. Altered serotonergic activity
in women with dysphoric premenstrual syndromes. Int’l J Psychiatry Med 1993;23:1-27.
42.
Hammarback S, Backstrom T. Induced anovulation as treatment of premenstrual
tension syndrome. Acta Obstet Gynecol
Scand 1988;67:159-166.
43.
Harrison WM, Endicott J, Rabkin JG, Nee JC, Sandberg
D. Treatment of premenstrual dysphoria
with alprazolam and placebo. Psychopharmacol
Bull 1987;23:150-153.
44.
Haskell SG, Richardson ED, Horwitz RI. The effect
of estrogen replacement therapy on cognitive function in women: A critical review
of the literature. J Clin Epidem 1997; 50:1249-1264.
45.
Hatotani N, Nomara J. Neurobiology of Periodic Psychoses. New York:Igaku-Shoin Toyko;1983.
46.
Hurd MW, Ralph MR. The significance of circadian
organization for longevity in the golder hamster. J of Bio Rhythms 1998;13:430-436.
47.
Jakubowicz DL, Godard E, Dewhurst J. The treatment of premenstrual tension with
mefenamic acid: Analysis of prostaglandin concentrations. Br J Obstet Gynaecol 1984; 91:78-84.
48.
Jansson R, Bernander S, Karlesson A, et al. Autoimmune
thyroid depression in the postpartum period. J Clin Endocrinol Metab 1984;58:681-687.
49.
Jones DY. Influence
of dietary fat and on self-reported menstrual symptoms. Physiol Behav 1987;40:483-487.
50.
Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill
JL, Rosenthal NE. Seasonal variation in behavioral responses to m-CPP in patients
with seasonal affective disorder and controls. Biological Psychiatry 1993;33:496-504.
51.
Kasper S, Sack DA, Wehr TA, et al. Nocturnal TSH
and prolactin secretion during sleep deprivation and prediction of antidepressant
response in patients
with major depression. Biol Psychiatry
1988;24:631-641.
52.
Kendall DA, Stancel AM, Einna SJ. Imipramine: Effect
of ovarian steroids on modification in serotonin receptor binding. Science 1981;211:1183-1185.
53.
Kendell RE, Chalmers JC, Platz C. Epidemiology
of puerperal psychoses. Br J Psychiatry
1987;150:662-673.
54.
Klaiber EL, Broverman DM, Vogel W, et al. Estrogen
therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-554.
55.
Kraeplin E. Manic depressive insanity and paranoia.
Edinburgh:Livingstone; 1921.
56.
Kukopulos A, Reginaldi P, Laddomada GF, et al:
Course of the manic depressive cycle and changes caused by treatments. Pharmacopsychiatry 1980;13:156-167.
57.
Kupfer DJ, Carpenter LL, Frank E. Possible role
of antidepressants in precipitating mania and hypomania in recurrent depression.
Am J Psychiatry 1988;145:804-808.
58.
Lam RW, Terman M, Wirz-Justice A. Light therapy
for depressive disorders: Indications and efficacy. Mod Probl Pharmacopsychiatry
1997;25:215-34.
59.
Lazarus JH, Hall R, Othman S, Parkes AB, Richards
CJ, McCulloch B, Harris B. The clinical spectrum of postpartum thyroid disease.
QJM 1996;89:429-435.
60.
Maskall DD, Lam RW, Misri S, Carter D, Kuan AJ,
Yatham LN, Athanasios PZ. Seasonality of symptoms in women with late luteal
phase dysphoric disorder. Am J Psychiatry 1997;154:1436-1441.
61.
Meager I, Milgrom J. Group treatment for postpartum
depression: A pilot study. Australian and New Zealand J of Psychiatry 1996;30:852-860.
62.
McEwen BS. Clinically-relevant basic science studies
of gender differences and sex hormone effects, in press.
63.
McEwen BS, Parsons B. General steroid action on
the brain: Neurochemistry and neuropharmacology. Ann Rev Pharmacol Toxicol 1982;22:555-598.
64.
Mira M, McNeil D, Fraser IS, Vizzard J, Abraham
S. Mefenamic acid in the treatment of
premenstrual syndrome. Obstet Gynecol
1986;68:395-398.
65.
Morin LP, Fitzgerald KM, Zucker I. Estradiol shortens
the period of hamster circadian rhythms. Science 1977;196:305-306.
66.
Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual
syndrome by combined use of gonadotropin-releasing horome agonist and estrogen/progesterone.
J Clin Endocrinol Metab 1991;72:252A-252F.
67.
Muse KN, Cetel NS, Futterman LA, Yen SSC. The premenstrual syndrome: Effects of "medical
ovariectomy." N Engl J Med 1984;311:1345-1349.
68.
Neumeister A, Praschak-Rieder N, Hebelmann B, Rao M, Gluck J, Kasper S. Effects
of tryptophan depletion on drug-free patients with seasonal affective disorder
during a stable response to bright light therapy. Arch Gen Psych 1997;54:133-138.
69.
O'Brien PM, Craven D, Selby C, Symonds EM. Treatment of premenstrual syndrome by spironolactone.
Br J Obstet Gynaecol 1979;86:142-147.
70.
Oppenheim G. A case of rapid mood cycling with
estrogen: Implications for therapy. J Clin Psychiatry 1984;45:34-35.
71.
Parker DC, Rossman LG, Vanderloom EF. Sleep related,
nyctohemeral and briefly episodic variation on human plasma prolactin concentrations.
J Clin Endocrinol Metab 1973;36:1119-1124.
72.
Parry BL, Berga SL, Kripke DF, Klauber MR, Laughlin
GA, Yen SSC, Gillin JC. Altered waveform of plasma nocturnal melatonin secretion
in premenstrual depression. Arch Gen
Psychiatry 1990;47:1139-1146.
73.
Parry BL, Berga SL, Mostofi N, Klauber MR, Resnick
A. Plasma melatonin circadian rhythms during the menstrual cycle and after light
therapy in premenstrual dysphoric disorder and normal control subjects. J Bio
Rhythms 1997;12:47-64.
74.
Parry BL, Berga SL, Mostofi N, Sependa PA, Kripke
DF, Gillin JC. Morning vs. evening bright
light treatment of late luteal phase dysphoric disorder. Am J Psychiatry 1989; 146:1215-1217.
75.
Parry BL, Cover H, LeVeau B, et al. Early vs late
partial sleep deprivation in premenstrual depression and normal control subjects.
Am J Psychiatry 1995;152:404-412.
76.
Parry BL, Gerner RH, Wilkins JN et al. CSF and
endocrine studies of premenstrual syndrome.
Neuropsychopharmacology 1991;5:127-137.
77.
Parry BL, Mahan AM, Mostofi N, Klauber MR, Lew
GS, Gillin JC. Light therapy of late
luteal phase dysphoric disorder: An extended study. Am J Psychiatry, 1993;150:1417-1419.
78.
Parry BL, Rosenthal NE, Tamarkin L, Wehr T. Treatment
of a patient with seasonal premenstrual syndrome. Am J Psychiatry 1987;144:762-766.
79.
Parry BL, Rush AJ. Oral contraceptives and depressive
symptomatology: Biologic mechanisms. Compr Psychiatry 1979;20:347-358.
80.
Parry BL, Wehr TA. Therapeutic effect of sleep
deprivation in patients with premenstrual syndrome. Am J Psychiatry 1987;144:808-810.
81.
Post RM, Kramlinger KG, Joffe RT, Roy-Byrne PP,
Rosoff A, Frye MA, Huggins T. Rapid cycling bipolar affective disorder: Lack
of relation to hypothyroidism. Psychiatry Res 1997;72:1-7.
82.
Post RM, Rubinow DR, Ballenger JC. Conditioning,
sensitization and kindling: Implications for the course of affective illness.
In Post RM, Ballenger JC (eds): Neurobiology of Mood Disorders.
Baltimore/London: Williams and Wilkins; 1984.
83.
Prange AJ, Wilson IC, Rabon AM, et al. Enhancement
of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 1969;126:457-469.
84.
Price WA, Dimarzio L. Premenstrual tension syndrome
in rapid-cycling bipolar affective disorder. J Clin Psychiatry 1986;47:415-417.
85.
Puolakka J, Makarainen L, Viinikka L, Ylikorkala
O. Biochemical and clinical effects
of treating the premenstrual syndrome with prostaglandin synthesis precursors.
J Reprod Med 1985;30:149-153.
86.
Ramey JN, Burrow GN, Polackwich RJ, Donabedian
RK. The effect of oral contraceptive steroids on the response of thyroid stimulating
hormone to thyrotropin releasing hormone. J Clin Endocrinol Metab 1975;40:712-714.
87.
Reich T, Winokur G. Postpartum psychoses in patients
with manic depressive disorder. J Nerv
Ment Dis 1970;151:60-68.
88.
Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman
AB. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological
performance. Hormones and Behavior 1998; 34:171-82.
89.
Richter CP, Jones GS, Biswanger L. Periodic phenomena
and the thyroid. Arch Neurol Psychiatry 1959;81:117-139.
90.
Rickles K, Freeman E, Sondheimer S. Buspirone in treatment of premenstrual syndrome
(letter). Lancet 1989;1:777.
91.
Robins LN, Helzer JE, Weissman MM, et al. Lifetime
prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-958.
92.
Rosenthal NE, Sack DA, James SP, Parry BL, Mendelson
WB, Tamarkin L, Wehr TA. Seasonal affective disorder and phototherapy.
Ann NY Acad Sci 1985;453:260-269.
93.
Roy-Byrne PP, Uhde TW, Post RM. Effects of one
nights sleep deprivation on mood and behavior in panic disorder. Arch Gen Psychiatry 1986;43:895-900.
94.
Rubinow DR, Roy-Byrne P. Premenstrual syndromes: Overview from a methodologic
perspecitve. Am J Psychiatry 1984;141:163-172.
95.
Sack DA, Duncan W, Rosenthal NE, et al. The timing
and duration of sleep in partial sleep deprivation therapy of depression.
Acta Psychiatr Scand 1988;77:219-224.
96.
Sack DA, James SP, Rosenthal NE, et al. Deficient
nocturnal surge of TSH secretion during sleep and sleep deprivation in rapid
cycling bipolar illness. Psychiatry
Res 1988; 23:179-191.
97.
Sarno AP, Miller EJ, Lundblad EG. Premenstrual syndrome: Beneficial effects of
periodic, low-dose danazol. Obstet Gynecol
1987;70:33-36.
98.
Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow
DR. Differential behavioral effects of gonadal steriods in women with and in
those without premenstrual syndrome. N Eng J Med 1998;338:209-216.
99.
Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam
GR, Rubinow DR. Lack of effect of induced menses on symptoms in women with premenstrual
syndrome. N Eng J Med 1991;324:1174-1179.
100. Schou
M. Treating recurrent affective disorders during and after pregnancy. Drug Safety
1998;18:143-152.
101. Schwartz
PJ, Murphy DL, Wehr TA, Garcia-Borreguero D, Oren D, Moul D, Ozaki N, Snelbaker
AJ, Rosenthal NE. Effects of meta-chlorophenylpiperazine infusions in patients
with Seasonal Affective Disorder and healthy control subjects. Arch Gen Psych
1997;54:375-385.
102. Sherwin
BB. Estrogenic effects on memory in women. Ann NY Acad of Sci 1994; 743:213-30.
103. Singh
M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in
a reversible learning impairment and compromised cholinergic function in female
Sprague-Dawley rats. Brain Res 1994;644:305-312.
104. Smith
S, Rinehart JS, Ruddock VE, Schiff I. Treatment
of premenstrual syndrome with Alprazolam: Results of a double-blind, placebo-controlled,
randomized crossover clinical trial. Obstet Gynecol 1987;70:37-43.
105. Spinelli
MG. Interpersonal psychotherapy for depressed antepartum women: A pilot study.
Am J Psychiatry 1997;154:1028-1030.
106. Spitz
IM, Zylber-Haran A, Trestian S. The thyrotropin (TSH) profile in isolated gonadotropin
deficiency: A model to evaluate the effect of sex steroids on TSH secretion.
J Clin Endocrinol Metab 1983;57:425-430.
107. Stancer
HC, Persad E. Treatment of intractable rapid cycling manic depressive disorder
with levothyroxine. Arch Gen Psychiatry
1982;39:311-312.
108. Steiner
M, Korzekwa M, Lamont J, Wilkins A. Intermittent fluoxetine dosing in the treatment
of women with premenstrual dysphoria. Psychopharm Bull 1997;33:771-774.
109. Steiner
M, Steinberg S, Stewart D, Carter D, Berger C, et al. N Eng J of Med 1995;332:
1529-1534.
110. Suhail
K, Cochrane R. Seasonal variations in hospital admissions for affective disorders
by gender and ethnicity. Soc Psychiatry Psychiatr Epidem 1988;33:211-217.
111. Tam
LW, Parry BL. New findings in the treatment of depression at menopause. Submitted
for publication, 1998.
112. Thomas
EMV, Armstrong SM. Effect of ovariectomy and estradiol on unity of female rat
circadian rhythms. Am J Physiol 1989;257:R1241-1250.
113. Tondo
L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive
disorders. Am J Psychiatry 1998;155:1434-1436.
114. Transbol
I, Christiansen C, Baastrup PC. Endocrine effects of lithium. Acta Endocrinol 978;87:759-767.
115. Trixler
M, Tenyi T. Antipsychotic use in pregnancy. What are the best treatment options?
Drug Safety 1997;16:403-10.
116. Vellacott
ID, Shroff NE, Pearce MY, Stratford ME, Akbar FA. A double-blind placebo evaluation of spironolactone in the premenstrual
syndrome. Curr Med Res Opin 1987; 10:450-456.
117. Videbech
P, Gouliaev G. First admission with puerperal psychosis: 7-14 years of follow-up.
Acta Psychiatr Scand 1995;91:167-173.
118. Warner
R, Appleby L, Whitton A, Faragher B. Demographic and obstetric risk factors
for postnatal psychiatric morbidity. Brit J Psychiatry 1996;168:607-611.
119. Watts
JF, Butt WR, Logan Edwards R. A clinical
trial using danazol for the treatment of premenstrual tension. Br J Obstet Gynecol 1987;94:30-34.
120. Wehr
TA, Goodwin FK. Rapid cycling in manic depressives induced by tricyclic antidepressants.
Arch Gen Psychiatry 1979;36:555-559.
121. Wehr
TA, Sack DA, Jacobsen FM, et al. Phototherapy of seasonal affective disorder:
Time of day and suppression of melatonin are not critical for antidepressant
effects. Arch Gen Psychiatry 1986;43:870-875.
122. Wehr
TA, Sack DA, Rosenthal NE. Rapid cycling
affective disorder: Contributing factors and treatment responses of 51 patients.
Am J Psychiatry 1988;145:179-184.
123. Wehr
TA, Sack DA, Rosenthal NE. Seasonal
affective disorder with summer depression and winter hypomania. Am J Psychiatry 1987;144:1602-1603.
124. Wehr
TA, Sack DA, Rosenthal NE. Sleep reduction
as a final common pathway in the genesis of mania. Am J Psychiatry 1987;144:201-204.
125. Weissman
MM, Gammon D, John K, et al. Children of depressed parents: Increased psychopathology
and early onset of major depression. Arch Gen Psychiatry 1987;44:847-53.
126. Weissman
MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen
Psychiatry 1977;34:98-111.
127. Weissman
MM, Leaf PJ, Holzer CE, et al. The epidemiology of depression: An update on
sex differences in rates. J Affect Disord
1984;7:179-188.
128. Werch
A, Kane RE. Treatment of premenstrual
tension with metolazone: A double-blind evaluation of a new diuretic. Curr Therapeutic Res. 1976;19:565-572.
129. West
CP, Hillier H. Ovarian suppression with the gonadotrophin-releasing hormone
agonist goserelin (Zoladex) in management of the premenstrual tension syndrome.
Human Reproduction 1994;9:1058-1063.
130. Wever
RA. Properties of human sleep-wake cycles: Parameters of internally synchronized
free running rhythms. Sleep 1984;7:27-51.
131. Whybrow
PC, Prange AJ. A hypothesis of thyroid-catecholamine receptor interaction. Arch Gen Psychiatry 1981;38:106-113.
132. Williams
MJ, Harris RI, Dean BC. Controlled trial
of pyridoxine in the premenstrual syndrome. J Int Med Res 1985;13:174-179.
133. Wirz-Justice
A, Wever RA, Aschoff J. Seasonality in freerunning rhythms in man. Naturwissenschaften
1984;71:316-319.
134. Wise
PM, Krajnak KM, Kashon ML. Menopause: The aging of multiple pacemakers. Science
1996;273:67-70.
135. Wisner
KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant
pairs. J Clin Psychopharm 1998;18:167-169.
136. Wisner
KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am
J of Psychiatry 1996;153:1132-1137.
137. Wood
C, Jakubowicz D. The treatment of premenstrual
symptoms with mefenamic acid. Br. J.
Obstet Gynaecol 1980;87:627-630.
138. Ylostalo
P, Kauppila A, Puolakka J, Ronnberg L Janne O.
Bromocriptine and norethisterone in the treatment of premenstrual yndrome.
Obstet Gynecol 1982;59:292-98.
139. Yonkers
KA, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as a treatment for premenstrual
dysphoric disorder. J of Clin Psychopharm 1996;16:3-8.
140. Yonkers
KA, Halbreich U, Freeman E, Brown C, Endicott J et al. Symptomatic improvement
of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled
trial. JAMA 1997;278:983-988.
141. Yonkers
KA, White K. Premenstrual exacerbation
of depression: one process or two? J
Clin Psychiatry 1992;53:289-292.
142. Young
SA, Hurt PH, Benedek DM, Howard RS. Treatment of premenstrual dysphoric disorder
with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled
crossover trial. J Clin Psychiatry 1998;59:76-79.
143. Zweifel
JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy
upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
Back to Chapter
published 2000